Welcome to our dedicated page for Travelers Compan SEC filings (Ticker: TRV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Travelers Companies, Inc. filings document the disclosure record of a NYSE-listed property casualty insurer with common stock trading under TRV. Recent Form 8-K reports furnish quarterly results of operations, financial-condition updates, financial supplements and other material events tied to the company’s insurance operations and investment portfolio.
Travelers’ proxy materials cover board elections, executive compensation, pay-versus-performance disclosures and shareholder governance matters. Other filings record board composition changes, registered securities information and capital-structure activity, including senior note issuance and underwriting agreement disclosures.
A holder of TRV common stock filed a Form 144 notice to sell 5,000 shares through Fidelity Brokerage Services on the NYSE, with an approximate sale date of 11/21/2025. The filing lists an aggregate market value for the planned sale of $1,452,849.24 and shows 223,063,417 shares of the same class outstanding.
The seller acquired these 5,000 shares on 11/21/2025 by exercising a stock option that had been granted on 02/05/2019, paying the purchase price in cash. The signatory represents that they are not aware of any material adverse, nonpublic information about the issuer’s current or prospective operations when submitting this notice.
The Travelers Companies (TRV) filed a Form 4 for its Vice Chairman, reporting option exercises and open‑market sales on 11/12/2025 and 11/13/2025. The officer exercised 2,000 options at $139.83 on 11/12 and 1,803 options at $172.5 on 11/13.
On 11/12, the filing shows sales of 1,000 shares at $287 and 1,000 shares at $288. On 11/13, it shows sales of 803 shares at $289 and 1,000 shares at $290. Following the reported transactions, direct ownership is listed as 255,085.534 shares. Indirect holdings are disclosed as 1,710.706 shares in a 401(k) plan, 2,256 held by spouse, and 250 in trust for a stepson, with a disclaimer of beneficial ownership for those shares.
Travelers (TRV) filed a Form 144 notice for a proposed sale of 1,803 common shares through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $522,067 and an approximate sale date of 11/13/2025.
The seller acquired the shares via an option granted on 02/08/2022 and paid cash on 11/13/2025. Recent activity includes 2,000 shares sold on 08/22/2025 for $557,000 and 4,000 shares sold on 11/11/2025 for $1,138,780. Proceeds from these transactions go to the selling holder.
Travelers Companies, Inc. filed a Form 13F reporting its institutional holdings. The report lists 2 information-table entries with a combined market value of $132,120,181 and names 1 other included manager (Travelers Indemnity Co.). The filing is a routine quarterly holdings disclosure.
Travelers Companies (TRV): Form 144 filed for proposed insider sale. William H. Heyman filed a notice to sell 2,000 shares of TRV common stock with an aggregate market value of $575,000, with an approximate sale date of 11/12/2025. The broker listed is Fidelity Brokerage Services LLC, and the exchange named is the NYSE.
The shares to be sold were acquired on 11/12/2025 via an option granted on 02/02/2021, with payment in cash. Recent activity disclosed includes sales of TRV common stock by Heyman: 2,000 shares on 08/22/2025 for $557,000; 1,000 on 11/07/2025 for $280,000; 2,000 on 11/10/2025 for $563,000; and 4,000 on 11/11/2025 for $1,138,780.
The Travelers Companies (TRV) vice chairman reported option exercises and open‑market sales. From 11/07–11/11/2025, the insider exercised 7,000 stock options at an exercise price of $139.83 and sold 7,000 common shares in multiple transactions at prices including $280, $281, $282, a weighted average of $283.89, $285, and $286.
Following these transactions, directly held shares were 255,085.534, with an additional 1,710.706 shares listed under a 401(k) Plan. The filing notes shares held by a spouse and a trust for a stepson are disclaimed for beneficial ownership. Derivative holdings show 2,000 stock options remaining.
TRV: A holder filed a Form 144 notice to sell 4,000 shares of common stock through Fidelity Brokerage Services, with an aggregate market value of $1,138,780.00. The notice lists an approximate sale date of 11/11/2025 on the NYSE.
The securities were acquired on 11/11/2025 via an option granted on 02/02/2021, with cash payment on 11/11/2025. As context, 223,063,417 shares were outstanding. Recent activity by the same seller includes 2,000 shares sold on 08/22/2025 for $557,000.00, 1,000 shares on 11/07/2025 for $280,000.00, and 2,000 shares on 11/10/2025 for $563,000.00.
The notice affirms the seller does not know of undisclosed material adverse information.
TRV: A shareholder filed a Form 144 notice to sell up to 2,000 common shares, with an aggregate market value of $563,000. The approximate sale date is 11/10/2025 through Fidelity Brokerage Services LLC on the NYSE. The shares were acquired via an option granted on 02/02/2021 and paid in cash on 11/10/2025.
In the past three months, the filer sold 2,000 shares on 08/22/2025 for $557,000 and 1,000 shares on 11/07/2025 for $280,000. Shares outstanding were 223,063,417; this is a baseline figure, not the amount being sold.
TRV — Notice of proposed sale under Rule 144. A holder filed a Form 144 to sell up to 1,000 shares of common stock with an aggregate market value of $280,000. The filing lists an approximate sale date of November 7, 2025, with sales to be made on the NYSE through Fidelity Brokerage Services LLC.
The disclosure also notes prior sales in the last three months: William H. Heyman sold 2,000 common shares on August 22, 2025 for gross proceeds of $557,000.
The Travelers Companies (TRV) EVP & CFO reported an option exercise and share sale. On 11/06/2025, the officer exercised 25,000 stock options at $139.83 per share and sold 25,000 common shares at a weighted average price of $278.2502.
Following these transactions, the officer beneficially owned 26,931.82 shares directly. Derivative holdings included 11,037 stock options remaining. The sales price reflects multiple trades within the $278.25 to $278.252 range.